K884544Substantially Equivalent
Dade Factor VIII Chromogenic Assay
Baxter Healthcare Corporation, Miami FL / Traditional, Substantially Equivalent
K884544 is the FDA 510(k) clearance record for DADE FACTOR VIII CHROMOGENIC ASSAY, a class II device, cleared for Baxter Healthcare Corp on under FDA product code GGP (Test, Qualitative And Quantitative Factor Deficiency). FDA records list 570 510(k) clearances for Baxter Healthcare Corp, from to . As of , FDA records show one recall naming K884544.
Clearance record
- Decision date
- Received
- (60 days to decision)
- Product code
- GGP Test, Qualitative And Quantitative Factor Deficiency
- Regulation
- 21 CFR 864.7290
- Device class
- Class II
- Review panel
- Hematology
- Applicant
- Baxter Healthcare Corp P.O.Box 520672, Miami FL
- Third party review
- No
Clearances, product code GGP
Trailing 12 monthsFDA records hold no clearances under product code GGP in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
